lobbying_activities: 3246625

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3246625	a210022b-0de2-403c-96ba-09ca542b4224	Q3	CGCN GROUP, LLC	76992	ERADIVIR	2024	third_quarter	DIS	Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA) and Project BioShield FY24.	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2024-10-17T23:14:21-04:00